CoreCap Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86K Sell
4
-7
-64% -$2.94K ﹤0.01% 2554
2026
Q1
$4.16K Sell
11
-2
-15% -$857 ﹤0.01% 2230
2025
Q4
$5.56K Buy
13
+4
+44% +$1.74K ﹤0.01% 2166
2025
Q3
$4.03K Sell
9
-2
-18% -$906 ﹤0.01% 2221
2025
Q2
$5.36K Buy
11
+4
+57% +$2.28K ﹤0.01% 2095
2025
Q1
$4.31K Sell
7
-1
-13% -$568 ﹤0.01% 2136
2024
Q4
$4.24K Sell
8
-140
-95% -$78.9K ﹤0.01% 2009
2024
Q3
$88.9K Buy
148
+144
+3,600% +$81.6K ﹤0.01% 963
2024
Q2
$2.17K Buy
+4
New +$2.29K ﹤0.01% 1309

Other funds holding CHE

CoreCap Advisors's CHE Position: Q2 2026 in Review

CoreCap Advisors reduced its Chemed (CHE) stake by 64% in Q2 2026, selling an estimated $2.94K and leaving 4 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2554.

CoreCap Advisors first reported a position in CHE in Q2 2024 and has held it in 9 quarters since. The position peaked at $88.9K in Q3 2024. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • CoreCap Advisors held 4 shares of Chemed worth $1.86K as of Q2 2026.
  • CoreCap Advisors sold 7 Chemed shares in Q2 2026, an estimated $2.94K.
  • Chemed made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2554 holding.
  • CoreCap Advisors first reported a position in Chemed in Q2 2024 and has held it in 9 quarters since.
  • CoreCap Advisors's Chemed position peaked at $88.9K in Q3 2024.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.